# Editas Medicine, Inc.: Form 8-K, filed Oct 22, 2024

- Company: [Editas Medicine, Inc.](/companies/edit.md) (CIK 1650664)
- Form: 8-K
- Filed: 2024-10-22
- Accepted by EDGAR: Oct 22, 2024, 07:04 ET
- Period: 2024-10-22
- Accession: 0001650664-24-000114
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1650664/000165066424000114/edit-20241022.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650664/000165066424000114/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650664/000165066424000114/edit-20241022.htm

Filed Oct 22, 2024.
Source: SEC EDGAR, the filing index for accession 0001650664-24-000114. Last ingested by Listed: Nov 10, 2026, 02:10 ET. No prices; not investment advice.